Stay updated with breaking news from Statistics Review. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
News Release Media Contacts: Zayn Qureshi +44 7760 334666 Email: zqureshi@its.jnj.com Investor...
Early data show an overall survival trend favoring the combination of amivantamab and lazertinib compared to osimertinib; consistent results seen in...
The addition of PARP inhibitors for the treatment of patients with BRCA-mutated advanced ovarian cancer has provided clinicians with a stronger set of treatment options. Looking at how the BRCA mutation responds to these inhibitors is then vital to deciding the patient’s treatment path.
Liquid biopsies could usher in a paradigm shift in cancer detection and grow exponentially.
Liquid biopsies could usher in a paradigm shift in cancer detection and grow exponentially.